Recent Updates
Recently added Catalysts
BSX

Boston Scientific to Participate in 37th Annual J.P. Morgan Healthcare Conference Boston Scientific Corporation (NYSE: BSX) will participate in the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 in San...

Key Takeaway: MARLBOROUGH, Mass. , Dec. 21, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) will participate in the 37 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 in San Francisco, California . Mike Mahoney , chairman and chief executive officer, wi

Full Press Release Details

MARLBOROUGH, Mass. , Dec. 21, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) will participate in the 37 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 in San Francisco, California .
Mike Mahoney , chairman and chief executive officer, will present at approximately 8:00 a.m. PST . At 8:30 a.m. PST , Mahoney will be joined by Dan Brennan , executive vice president and chief financial officer, Professor Ian Meredith , executive vice president and global chief medical officer, and Susie Lisa , vice president, Investor Relations, in a question-and-answer session with the host analyst and audience members.
A live webcast of the presentation and question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com . A replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of the event.
About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook .
CONTACTS
Media: Investors:
Kate Haranis Susie Lisa, CFA
508-683-6585 (office) 508- 683-5565 (office)
Media Relations Investor Relations
Boston Scientific Corporation Boston Scientific Corporation
[email protected] [email protected]
SOURCE Boston Scientific Corporation

Related Links

21 %

Last updated: Dec 21, 2018